DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for Blood Glucose Test Strips 2017 - MedCore" report to their offering.
The U.S. blood glucose test strip market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose test strip market was the personal segment. Personal test strips are used by individuals who use personal meters to perform self-monitoring of blood glucose (SMBG) on a daily basis.
The personal test strip market is further segmented by insurance type and comprises the Medicare/Medicaid, managed care and cash sub-segments. CMS competitive bidding had a significant impact on the personal test strip market after substantial reimbursement cuts in July 2013 and July 2016, respectively.
Professional test strips are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Meters in the hospital are typically more technologically advanced than meters found in other settings and often involve software systems which analyze data and provide higher accuracy than personal meters.
The growing number of individuals living in nursing homes or other long term care facilities who have diabetes will be the primary driver of market growth. However, as assisted living is becoming more popular, patients are opting for their own personal meters. Long term care centers are also starting to enforce one patient-one meter' policies, shifting the focus away from professional meters and test strips.
Key Topics Covered:
Table Of Contents I
List Of Figures Iii
List Of Charts V
Executive Summary
U.S. Diabetes Monitoring, Treatment And Drug Delivery Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
Research Methodology
Companies Mentioned
Sanofi
Novo Nordisk
Eli Lilly
Medtronic
Johnson & Johnson
Becton Dickinson
Abbott
Roche
DexCom
Ascensia
Insulet
Trividia Health
Tandem
Nova Biomedical
Valeritas
For more information about this report visit http://www.researchandmarkets.com/research/xxjbxt/us_market_report
